Paracetamol poisoning: Which nomogram should we use?

Emergency Medicine

Volumn 15, Issue 5-6, 2003, Pages 486-496

  Reid, Duncan ^a   Hazell, Wayne ^b  

^a NORTH SHORE HOSPITAL   (New Zealand)

^b NONE

Author keywords

Acetylcysteine; Drug toxicity; Paracetamol acetaminophen; Poisoning; Therapeutics

Indexed keywords

ACETYLCYSTEINE; MERCAPTAMINE; PARACETAMOL;

ACCREDITATION; ANALGESIA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; AUSTRALIA; BRONCHOSPASM; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG INTOXICATION; DRUG SAFETY; EMERGENCY MEDICINE; EMERGENCY TREATMENT; EVIDENCE BASED MEDICINE; FLUSHING; HEALTH SURVEY; HOSPITAL DEPARTMENT; HUMAN; HYPOTENSION; LIVER INJURY; LIVER TOXICITY; MEDICAL SPECIALIST; NAUSEA; NEW ZEALAND; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; REVIEW; SIDE EFFECT; TACHYCARDIA; TRAINING; VOMITING;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; AUSTRALIA; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; HUMANS; NEW ZEALAND; POISONING; PRACTICE GUIDELINES; QUESTIONNAIRES;

EID: 0344825866     PISSN: 10356851     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2026.2003.00507.x     Document Type: Review

References (63)

1. Thomson JS, Prescott LF. Liver damage and impaired glucose tolerance after paracetamol overdose. BMJ 1966; 2: 506-7.
2. Davidson DGD, Eastham WN. Acute liver necrosis following overdose of paracetamol. BMJ 1966; 2: 497-9.
3. Prescott LF, Newton RW, Swainson CP, Wright N, Forrest ARW, Matthew H. Successful treatment of severe paracetamol overdose with cysteamine. Lancet 1974; i: 588-92.
4. Prescott LF, Park J, Sutherland GR, Smith IJ. Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet 1976; ii: 109-13.
5. Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 1977; ii: 432-4.
6. Paterson RG, Rumack BH. Treating acute acetaminophen poisoning with acetylcysteine. JAMA 1977; 237: 2406-7.
7. Herren K, Clarke S. Vomiting in paracetamol overdose. Emerg. Med J. 2002; 19: 248.
8. Rumack BH, Matthew H. Acetaminophen Poisoning and Toxicity. Pediatrics 1975; 55: 871-6.
9. Prescott LF, Wright N, Roscoe P, Brown SS. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdose. Lancet 1971; ii: 519-22.
10. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic Necrosis: Role of drug metabolism. J. Pharmacol. Exp Ther. 1973; 187:185-94.
11. Rumack BH. Acetaminophen hepatotoxicity: The first 35 years. J. Toxicol. Clin. Toxicol. 2002; 40: 3-20.
12. James O, Lesna M, Roberts SH et al. Liver damage after paracetamol overdose-comparison of liver-function tests, fasting serum bile acids, and liver histology. Lancet 1975; ii: 579-81.
13. Douglas AP, Hamlyn AN, James O. Controlled trial of cysteamine in the treatment of acute paracetamol (acetaminophen) poisoning. Lancet 1976; i: 111-15.
14. Piperno E, Berssenbruegge DA. Reversal of experimental paracetamol toxicosis with N-Acetylcysteine. Lancet 1976; ii: 738-9.
15. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 1979; 2: 1097-100.
16. Prescott LF. Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. Arch. Intern. Med. 1981; 141: 386-9.
17. Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen overdose 662 cases with evaluation of oral acetylcysteine treatment. Arch. Intern. Med. 1981; 141: 380-5.
18. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-Acetylcysteine in the treatment of acetaminophen overdose. N. Eng. J. Med. 1988; 319: 1557-62.
19. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: a 48-hour intravenous N-Acetylcysteine treatment protocol. Ann. Emerg. Med. 1991; 20: 1058-63.
20. Routledge P, Vale JA, Beteman DN et al. Paracetamol (Acetaminophen) Poisoning. BMJ 1998; 317:1609-10.
21. Barnes J, Abban M, Howarth P. Executive action is needed to change national guidelines. BMJ 1998; 317: 1654a.
22. Brandwene EL, Williams SR, Tunget-Johnson C, Turchen SG, Manoguerra AS, Clark RF. Refining the level for anticipated hepatotoxicity in acetaminophen poisoning. J. Emerg. Med. 1996; 14: 691-5.
23. Ravinuthala RS. Paracetamol (acetaminophen) poisoning. BMJ 1998; 317: 1609-10.
24. Bridger S, Henderson K, Glucksman E, Ellis AJ, Henry JA, Williams R. Deaths from low dose paracetamol poisoning. BMJ 1998; 316:1724-5.
25. Cameron MG. Lower threshold has probably not overburdened hospital services in Gloucester. BMJ 1998; 317: 1654a.
26. Brandon G. Guidelines are under review. BMJ 1998; 317: 1654a.
27. McAliskey DP. Several issues were not considered in the article. BMJ 1998; 317: 1654a.
28. Aujla KS, Maclean VM, Richardson JR, Docherty EM. Nomogram does not show absolute concentration for treatment. BMJ 1998; 317: 1654a.
29. Thomas SHL. If in doubt use the antidote. BMJ 1998; 317: 1654a.
30. D'Costa DF. More evidence needed to change the recommendations. BMJ 1998; 317: 1654a.
31. Bridger S, Henderson K, Ellis AJ, Glucksman E, Williams R, Henry J. Authors reply. BMJ 1998; 317: 1654a.
32. Kwan D, Bartle WR, Walker SE. Abnormal serum transaminases following therapeutic doses of acetaminophen in the absence of known risk factors. Dig. Dis. Sci. 1995; 40:1951-5.
33. Patel F. The fatal paracetamol dosage-how low can you go? Med. Sci. Law. 1992; 32: 303-10.
34. Singer AJ, Carracio TR, Mofenson HC. The temporal profile of increased transaminase levels in patients with acetaminophen-induced liver dysfunction. Ann. Emerg. Med. 1995; 26: 49-53.
35. Woo OF, Mueller PD, Olsen KR, Anderson IB, Kim SY. Shorter duration of oral N-Acetylcysteine therapy for acute acetaminophen overdose. Ann. Emerg. Med. 2000; 35: 363-8.
36. Draganov P, Durrence H, Cox C, Reuben A. Alcohol-acetaminophen syndrome. Post. Med. 2000; 107:189-95.
37. Johnston SC, Pelletier LL. Enhanced hepatotoxicity of acetaminophen in the alcoholic patient. Medicine 1997; 76:185-91.
38. Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995; 22: 767-73.
39. Cheung L, Potts RG, Meyer KC. Acetaminophen treatment nomogram. N. Eng. J. Med. 1994; 330: 1907-08.
40. Whitcombe DC, Block GD. Association of acetaminophen hepatoxicty with fasting and ethanol use. JAMA 1994; 272: 1845-50.
41. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N. Engl. J. Med. 1997; 337:1112-17.
42. LaBreque DR, Mitros FA. Increased hepatotoxicty of acetaminophen in the alcoholic. Gastroenterology 1980; 78: 1310.
43. Licht H, Seeff LB, Zimmerman HJ. Apparent potential of acetaminophen toxicity by alcohol. Ann. Int. Med. 1980; 92: 511.
44. McClain CJ, Kromhaut JP, Peterson FJ, Holtzman JL. Potentiation of acetaminophen toxicity by alcohol. JAMA 1980; 244: 251-3.
45. Slattery JT, Nelson SD, Thummel KE. The complex interaction between ethanol and acetaminophen. Clin. Pharmacol. Ther. 1996; 60: 241-6.
46. Makin A, Williams R. Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdose. Q. J. Med 2000; 93: 341-9.
47. Carter EA. Enhanced acetaminophen toxicity associated with prior alcohol consumption in mice: prevention by N-acetylcysteine. Alcohol 1987; 4: 69-71.
48. Prasad JS, Chen NQ, Liu YX, Goon DJ, Holtzman JL. Effects of ethanol and inhibitors on the binding and metabolism of acetaminophen and N-acetyl-p-benzoquinone imine by hepatic microsomes from contol and ethanol treated rats. Biochem. Pharmacol. 1990; 40: 1989-95.
49. Girre C, Hispard E, Palombo S, N'Guyen C, Dally S. Increased metabolism of acetaminophen in chronically alcoholic patients. Alcohol Clin. Exp. Res. 1993; 17:170-3.
50. Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut 1988; 29: 1153-7.
51. Hung O, Nelson CS. Acetaminophen. In: Tintinalli, JE, Kelen, GD, Stapczynski, JS, eds. Emergency Medicine Plus - a Comprehensive Study Guide, 5th edn. New York, NY, USA: McGraw-Hill, 2000; S 13; ch 165.
52. Graudins A. Paracetamol. In: Cameron P, Jelinek G, Kelly A-M, Murray L, Heyworth J, eds. Textbook of Adult Emergency Medicine. London, UK: Churchill Livingstone, 2000; S 7; ch 10.
53. Salgia ADT, Kosnic SD. When acetaminophen use becomes toxic. Post. Med. 1999; 105:81-90.
54. Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995; 346:547-52.
55. Bray GP, Harrison PM, O'Grady JG, Tredger JM, Williams R. Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum. Exp. Toxicol. 1992; 11: 265-70.
56. Crippin JS. Acetaminophen Hepatotoxicity: Potentiation by Isoniazid. Am. J. Gastroenterol. 1993; 88: 590-2.
57. Wright N, Prescott LF. Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdose. Scot. Med. J. 1973; 18:56-8.
58. Australian Working Group in conjunction with the Australasian College for Emergency Medicine. Guidelines for the Management of Paracetamol Overdose in Adults. Ermington, New South Wales, Australia: SmithKline Beecham International, Consumer Healthcare, 1997.
59. Flanagan RJ, Meredith TJ. Use of N-Acetylcysteine in Clinical Toxicology. Am. J Med. 1991; 91: 131S-139S.
60. Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-Acetylcysteine. Ann. Emerg. Med. 1998; 31: 710-15.
61. Dawson AH, Henry DA, McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med. J. Aust. 1989; 150: 329-31.
62. Death after N-Acetylcysteine. Lancet 1984; i: 1421.
63. Mant TGK, Tempowski JH, Volans GN, Talbot JCC. Adverse reactions to acetylcysteine and effects of overdose. BMJ 1984; 289:217-19.